Veeva (VEEV) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth ...

In the latest trading session, Veeva Systems (VEEV) closed at $237.81, marking a +0.26% move from the previous day.

Spire Wealth Management lowered its holdings in shares of Veeva Systems Inc. (NYSE:VEEV – Free Report) by 50.1% in the fourth ...

CENTRAL TRUST Co decreased its position in shares of Veeva Systems Inc. (NYSE:VEEV – Free Report) by 11.0% during the 4th ...

Truist Financial analyst Jailendra Singh maintained a Hold rating on Medpace Holdings (MEDP – Research Report) today. The company’s shares ...

Introduction Cloud computing in the pharmaceutical industry refers to the use of cloud-based platforms and services to store, process, and anal ...

In an interview with ACT senior editor Andy Studna at SCOPE Summit, Garty, chief technology officer, clinical data, provided his key takeaways from a panel he participated in on the growing interest ...

Dan Rizzo, global head of Veeva Business Consulting, spoke with Pharmaceutical Executive about the state of product launches ...

Imagine a time when all your teams collaborate seamlessly. That’s what this year’s Veeva Commercial Summit posited as it commenced. Chris Moore, president of Veeva Europe, opened the ...

Truist Financial analyst Jailendra Singh reiterated a Buy rating on IQVIA Holdings (IQV – Research Report) today and set a price target of ...

The main focus in Teva’s innovative portfolio continues to be neuroscience and immunology, with clinical trials for three key ...